Oncologist Mikhail Blagosklonny’s Impact in the Scientific World

Oncologist Mikhail Blagosklonny needs no introduction in the science world. His exemplary works both in academia and health care speak volumes. Mikhail is an established scholar and researcher. Throughout his career, Mikhail has published more than two hundred and fifty oncology based publication. Thanks to the help of a college, Mr. Mikhail is helping create awareness of science-based research through a publication known as OncoTarget where he is a co-editor.

Dr. Mikhail is a specialist and his area of study is cancer and aging. Through the many years of research, Mikhail has been able to gain an interest and understanding in areas ranging from cellular and molecular biology to medical research including signal transduction, cellular senescence, cell cycle, and anticancer therapeutics. Through his research, Mikhail has been able to carry out new cancer treatment strategies and also studied cells behavior to determine how they can slow down aging in human beings. Over time, Mikhail has grown fond of these two research areas to thus establishing himself as the expert he is. Visit classroomvoices.org to read more about Mikhail.

Dr. Mikhail is a well-learned person. The oncologist is a graduate of First Pavlov State Medical University, St. Petersburg. It is while in the institution that Dr. Mikhail established his career foundation by studying an M.D. in Internal Medicine and later enrolled for a Ph.D. in Cardiology and Experimental Medicine. After graduation, Mikhail started his career at the New York Medical College, Valhalla where he was employed as an associate professor in 2002. Later he advanced his career by joining the Ordway Research Institute in New York as a senior scientist. His career-changing opportunity was in 2009 when he joined the Roswell Park Cancer Institute as a full Professor of Oncology, a position he holds to date.

Dr. Mikhail has a number of achievements under his name, however, the most significant one that brought him praises and admiration was his fresh concepts to the treatment of cancer in 2009. From his research, Mikhail Blagosklonny helped contribute to the treatment and care of cancer by introducing new methods and strategies. These methods are combined with the aging process of the cells to help a cancer patient manage the adverse effects of chemo and radiotherapy.

Know more: http://gettingstronger.org/tag/mikhail-blagosklonny/

Stem Cell Therapy for Lung Diseases

Lung Institute is a department of regenerative solutions specializing in stem cell therapy for a wide range of diseases. The two years old lung Institute based in Tampa has established a branch in Nashville and in the recent past the institute is projected to launch another branch in Scottsdale, Ariz. The institute directly markets its services through both broadcast and print media. The organization posted a half page advert in Tampa Bay time’s newspaper comparing the pros of stem cell therapy to Beatles.

In its first year of operation, lung institute confirmed that they successfully diagnosed over 400 patients in Tampa clinic and another 50 patients in Nashville. Off late, the institute has not published the outcome of its therapies, though, in an interview with Tampa times, Feinermal, a licensed medical practitioner confirmed that over 70 percent of patients have reaped benefits from treatments. For more info, visit lunginstitute.com.

From the underlying knowledge on the therapeutic potential of stem cells among other clinically accepted trials for non-lung diseases, it’s essential to move on and consider this approach in treating lung disease, see https://lunginstitute.com/lung-diseases/copd/. Though, there is little knowledge on possible effects that might occur as a result of administration of the stem cell therapy to clients with lung disease. Before undertaking the therapy its importance to note the treatment could lead to more adverse implications that could deteriorate client’s condition rather than to improve it. From the preceding, safety should be given the top priority.

Different stem cells are formed at different stages of life. These cells entails; embryonic stem cell which exists at the initial stages of growth of specific tissues or adult stem cell that only appears during fetal development and remains in the body throughout the life.

According to Cedars-Sinai, currently, there is only a few numbers of clinically accepted trials in the United States and Canada conducting investigations on stem cell therapy for lung diseases. The data can be easily accessed over national institute of health at Clinicaltrials.gov. Hopefully, more statistics on stem cell therapy will be provided in future.